Next Capital Management’s Exact Sciences EXAS Stock Holding History

Next Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-96	Closed	-$11K	–	431
2019 Q2	$11K	Buy	+96	New	+$9.67K	0.01%	416

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Next Capital Management's EXAS Position: Q3 2019 in Review

Next Capital Management sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 96 shares — an estimated $11K sold.

Next Capital Management first reported a position in EXAS in Q2 2019 and held it in 1 quarter. The position peaked at $11K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

Next Capital Management reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
Next Capital Management sold 96 Exact Sciences shares in Q3 2019, an estimated $11K.
Next Capital Management first reported a position in Exact Sciences in Q2 2019 and held it in 1 quarter.
Next Capital Management's Exact Sciences position peaked at $11K in Q2 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.